BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bastiancich C, Malfanti A, Préat V, Rahman R. Rationally designed drug delivery systems for the local treatment of resected glioblastoma. Adv Drug Deliv Rev 2021;177:113951. [PMID: 34461201 DOI: 10.1016/j.addr.2021.113951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Daisy Precilla S, Biswas I, Kuduvalli SS, Anitha TS. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion? Cell Signal 2022;:110350. [PMID: 35525406 DOI: 10.1016/j.cellsig.2022.110350] [Reference Citation Analysis]
2 Hauck M, Dittmann J, Zeller-plumhoff B, Madurawala R, Hellmold D, Kubelt C, Synowitz M, Held-feindt J, Adelung R, Wulfinghoff S, Schütt F. Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release. Pharmaceutics 2022;14:777. [DOI: 10.3390/pharmaceutics14040777] [Reference Citation Analysis]
3 Bausart M, Préat V, Malfanti A. Immunotherapy for glioblastoma: the promise of combination strategies. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-022-02251-2] [Reference Citation Analysis]
4 Kong X, Feng M, Wu L, He Y, Mao H, Gu Z. Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment. Drug Deliv 2022;29:1595-607. [PMID: 35612309 DOI: 10.1080/10717544.2022.2075984] [Reference Citation Analysis]
5 Wang D, Xing S, Peng F, Zhang X, Tan J, Hao X, Qiao Y, Ge N, Liu X. Microenvironment-responsive electrocution of tumor and bacteria by implants modified with degenerate semiconductor film. Bioactive Materials 2023;20:472-88. [DOI: 10.1016/j.bioactmat.2022.06.004] [Reference Citation Analysis]
6 Malfanti A, Catania G, Degros Q, Wang M, Bausart M, Préat V. Design of Bio-Responsive Hyaluronic Acid-Doxorubicin Conjugates for the Local Treatment of Glioblastoma. Pharmaceutics 2022;14:124. [PMID: 35057020 DOI: 10.3390/pharmaceutics14010124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liang R, Wu C, Liu S, Zhao W. Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers. Drug Deliv 2022;29:1620-30. [PMID: 35612318 DOI: 10.1080/10717544.2022.2075986] [Reference Citation Analysis]